(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide has been researched along with Asthma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barioni, NO; Green, FHY; Jendzjowsky, NG; Kelly, MM; Pye, RL; Roy, A; Tenorio-Lopes, L; Wilson, RJA; Wyatt, CN | 1 |
1 other study(ies) available for (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and Asthma
Article | Year |
---|---|
Preventing acute asthmatic symptoms by targeting a neuronal mechanism involving carotid body lysophosphatidic acid receptors.
Topics: Acrylamides; Animals; Asthma; Bridged Bicyclo Compounds, Heterocyclic; Carotid Body; Disease Models, Animal; Drug Evaluation, Preclinical; Lysophospholipids; Male; Rats, Inbred BN; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid; TRPV Cation Channels | 2018 |